Weekly equity research · Norway
Directional State
Find strength. See what is changing.
Screen the direction and strength of the latest completed weekly DSI reading, then check whether price agrees.
The market picture · all eligible NO equities
Where directional strength sits
One listing, one reading. The distribution shows how widely strong conditions are shared.
54 strong negative readings · 29 strong positive readings · strong means |DSI| ≥ 50.
View distribution values
- -100 to -80 (upper boundary excluded): 1 equities
- -80 to -60 (upper boundary excluded): 22 equities
- -60 to -40 (upper boundary excluded): 59 equities
- -40 to -20 (upper boundary excluded): 36 equities
- -20 to 0 (upper boundary excluded): 38 equities
- 0 to 20 (upper boundary excluded): 35 equities
- 20 to 40 (upper boundary excluded): 35 equities
- 40 to 60 (upper boundary excluded): 24 equities
- 60 to 80 (upper boundary excluded): 18 equities
- 80 to 100: 0 equities
These four views highlight changing conditions. Steady, neutral and newly available readings remain in the full screen.
The screener
Explore the weekly readings
Norway · 9 Oct 2026
| Equity | DSI / strength | 4-week change | Condition | 13-week DSI | Price & evidence |
|---|---|---|---|---|---|
1 CODE CodeLab Capital ASWeekly chart ↗ |
+79.5Strong · Positive | +13.1 ptsPrice +48.0% | Strengthening19 weeks in state | Fixed scale · −100 to +100 | In agreementStretched abovePartial data · typical volatility |
2 CONTX ContextVision AB (publ)Weekly chart ↗ |
+65.2Strong · Positive | +34.1 ptsPrice +16.9% | Strengthening6 weeks in state | Fixed scale · −100 to +100 | In agreementWithin usual rangeFull data · typical volatility |
3 SOFTX SoftOx Solutions ASWeekly chart ↗ |
+43.4Moderate · Positive | +36.0 ptsPrice -0.7% | Strengthening4 weeks in state | Fixed scale · −100 to +100 | In disagreementWithin usual rangeFull data · typical volatility |
4 MEDI Medistim ASAWeekly chart ↗ |
+39.1Moderate · Positive | +18.5 ptsPrice +14.2% | Strengthening8 weeks in state | Fixed scale · −100 to +100 | In agreementStretched aboveFull data · quiet volatility |
5 CRNA Circio Holding ASAWeekly chart ↗ |
+27.0Moderate · Positive | -23.9 ptsPrice -12.7% | Weakening53 weeks in state | Fixed scale · −100 to +100 | In disagreementWithin usual rangeFull data · quiet volatility |
6 OMDA Omda ASWeekly chart ↗ |
+23.7Light · Positive | +25.2 ptsPrice +7.4% | Strengthening3 weeks in state | Fixed scale · −100 to +100 | In agreementWithin usual rangeFull data · elevated volatility |
7 NYKD Nykode Therapeutics ASWeekly chart ↗ |
+14.0Light · Positive | -28.4 ptsPrice -12.9% | Weakening52 weeks in state | Fixed scale · −100 to +100 | In disagreementWithin usual rangeFull data · typical volatility |
8 ONCIN Oncoinvent ASAWeekly chart ↗ |
+13.8Light · Positive | -55.1 ptsPrice -48.0% | Weakening14 weeks in state | Fixed scale · −100 to +100 | In disagreementWithin usual rangeFull data · elevated volatility |
9 INIFY INIFY Laboratories ABWeekly chart ↗ |
-1.5Balanced · Positive | -11.1 ptsPrice +6.0% | Weakening18 weeks in state | Fixed scale · −100 to +100 | In agreementWithin usual rangePartial data · quiet volatility |
10 NORDH Nordhealth ASWeekly chart ↗ |
-2.3Balanced · Negative | +20.1 ptsPrice +12.0% | Improving80 weeks in state | Fixed scale · −100 to +100 | In disagreementWithin usual rangePartial data · typical volatility |
11 LIFE Lifecare ASAWeekly chart ↗ |
-6.5Balanced · Negative | +24.0 ptsPrice +44.5% | Improving50 weeks in state | Fixed scale · −100 to +100 | In disagreementWithin usual rangeFull data · typical volatility |
12 ZLNA Zelluna ASAWeekly chart ↗ |
-9.8Balanced · Positive | -18.8 ptsPrice -4.2% | Weakening38 weeks in state | Fixed scale · −100 to +100 | In disagreementWithin usual rangeFull data · typical volatility |
13 GENT Gentian Diagnostics ASAWeekly chart ↗ |
-11.2Light · Negative | -0.6 ptsPrice -1.0% | Steady51 weeks in state | Fixed scale · −100 to +100 | In agreementWithin usual rangePartial data · quiet volatility |
14 AZT ArcticZymes Technologies ASAWeekly chart ↗ |
-15.2Light · Negative | -2.0 ptsPrice -7.3% | Steady41 weeks in state | Fixed scale · −100 to +100 | In agreementWithin usual rangeFull data · quiet volatility |
15 ABTEC Aqua Bio Technology ASAWeekly chart ↗ |
-20.6Light · Negative | +0.4 ptsPrice -6.8% | Steady124 weeks in state | Fixed scale · −100 to +100 | In agreementWithin usual rangePartial data · quiet volatility |
16 TRMED Thor Medical ASAWeekly chart ↗ |
-27.3Moderate · Negative | -35.4 ptsPrice -5.2% | Deteriorating3 weeks in state | Fixed scale · −100 to +100 | In agreementWithin usual rangeFull data · typical volatility |
17 OBSRV Observe Medical ASAWeekly chart ↗ |
-29.9Moderate · Negative | -9.2 ptsPrice +1.1% | Deteriorating6 weeks in state | Fixed scale · −100 to +100 | In disagreementWithin usual rangeFull data · quiet volatility |
18 EXTX EXACT Therapeutics ASWeekly chart ↗ |
-39.1Moderate · Negative | +12.5 ptsPrice +15.7% | Improving151 weeks in state | Fixed scale · −100 to +100 | In disagreementWithin usual rangePartial data · typical volatility |
19 LYTIX Lytix Biopharma ASAWeekly chart ↗ |
-48.4Moderate · Negative | -1.3 ptsPrice -2.4% | Steady18 weeks in state | Fixed scale · −100 to +100 | In agreementWithin usual rangeFull data · typical volatility |
20 INDCT Induct ASWeekly chart ↗ |
-54.3Strong · Negative | +11.5 ptsPrice -13.5% | Improving33 weeks in state | Fixed scale · −100 to +100 | In agreementStretched belowFull data · typical volatility |
21 PHO Photocure ASAWeekly chart ↗ |
-62.4Strong · Negative | -4.0 ptsPrice -4.8% | Deteriorating33 weeks in state | Fixed scale · −100 to +100 | In agreementWithin usual rangeFull data · typical volatility |
22 NAVA Navamedic ASAWeekly chart ↗ |
-65.6Strong · Negative | +2.8 ptsPrice -4.0% | Steady38 weeks in state | Fixed scale · −100 to +100 | In agreementStretched belowFull data · typical volatility |
23 VISTN Vistin Pharma ASAWeekly chart ↗ |
-66.9Strong · Negative | -13.2 ptsPrice -4.7% | Deteriorating18 weeks in state | Fixed scale · −100 to +100 | In agreementWithin usual rangeFull data · typical volatility |
24 ABS Arctic Bioscience ASWeekly chart ↗ |
-68.5Strong · Negative | +1.6 ptsPrice -4.0% | Steady38 weeks in state | Fixed scale · −100 to +100 | In agreementWithin usual rangePartial data · typical volatility |
Reading the screen
Direction, strength and change answer different questions
Direction & strength
DSI is a signed reading from −100 to +100. Strength is its absolute value: strong ≥50, moderate 25–49.9, light 10–24.9, balanced below 10. Near zero, the established direction is retained until the opposite ±10 boundary is reached.
Change & price agreement
Four-week change is measured in DSI points, never percent. A negative reading can improve before turning positive. Price agrees when its four-week return follows the established direction; moves smaller than 0.5% are mixed.
How the ranking works
The default orders signed DSI from highest to lowest, then four-week change. Strongest in either direction orders by distance from zero. Change sorts place unavailable comparisons last. These describe conditions, not validated trading signals or probabilities.
Weekly coverage
Active equity listings with sufficient continuous history and a current reading are included. At least 52 completed observations are needed; gaps and unresolved splits restart the calculation. Partial data is labelled, not treated as full evidence. Country is the listing market.
Publication and data coverage
283 active equity listings checked; 268 eligible, including 52 with partial data. Excluded: 0 without history, 0 without current completed data, and 15 with insufficient continuous history or supporting evidence. Known full-week exchange closures are allowed. Cross-listings are separate listings.
Published 11 Oct 2026, 22:18 BST. Saved results refresh after the weekly rebuild. DSI remains a research prototype; a strong reading can coincide with a stretched price.